+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Myocardial Infarction Drug"

Myocardial Infarction Global Market Report 2024 - Product Thumbnail Image

Myocardial Infarction Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
CSL112 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

CSL112 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
FDY-5301 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

FDY-5301 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Selatogrel Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Selatogrel Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Olpasiran Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Olpasiran Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Pelacarsen Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Pelacarsen Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
From
Japan CL2020 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Japan CL2020 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Japan
Myocardial Infarction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myocardial Infarction - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 110 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2021 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • Global
From
Global Myocardial Infarction (MI) Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Myocardial Infarction (MI) Therapeutics Market 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Global
From
From
From
Myocardial Infarction Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Myocardial Infarction Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • March 2020
  • 1115 Pages
  • Global
From
Myocardial Infarction - Pipeline Review, H2 2020 - Product Thumbnail Image

Myocardial Infarction - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 385 Pages
  • Global
From
Loading Indicator

The Myocardial Infarction Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent heart diseases. Myocardial Infarction Drugs are used to treat acute myocardial infarction (AMI), also known as a heart attack. These drugs are used to reduce the risk of death and complications from AMI, such as heart failure, arrhythmias, and stroke. Commonly used Myocardial Infarction Drugs include anticoagulants, antiplatelet agents, beta-blockers, and statins. These drugs are used to reduce the risk of blood clots, reduce inflammation, and lower cholesterol levels. Some companies in the Myocardial Infarction Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more